市場調查報告書
商品編碼
1370520
制氧機市場:2023-2028 年全球產業趨勢、佔有率、規模、成長、機會與預測Oxygenators Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
2022年,全球製氧機市場規模達到2.442億美元。展望未來,IMARC Group預計到2028年市場規模將達到3.484億美元,2023-2028年年複合成長率(CAGR)為5.9%。
氧合器是指在醫療環境中常規使用的醫療設備,用於在外科手術過程中幫助交換患者血液中的氧氣和二氧化碳。該裝置與心肺機結合使用,以便在血流中斷或停止的手術過程中促進氣體交換。這些設備廣泛用於治療與心臟相關的疾病,例如心肺、呼吸和肺部疾病。因此,這些設備通常用於許多關鍵的手術,包括心肺旁路移植術 (CABG) 和冠狀動脈旁路移植術 (CABG)。
全球市場的主要動力是由於大眾中多種冠心病、骨科疾病和心血管疾病的盛行率不斷上升,導致住院人數不斷增加。這可以歸因於個人久坐的生活方式,導致各種與生活方式相關的疾病以及手術介入的需求大幅增加。此外,易患這些疾病的老年人口不斷增加也是市場的重要成長因素。此外,政府在醫療保健數位化、先進基礎設施建設和持續產品創新方面不斷增加的投資正在推動市場發展。由於醫療保健環境的改善,全球醫療機構對氧合器設備的需求和銷售量顯著增加。影響市場的其他一些因素包括主要參與者之間不斷增加的併購 (M&A)、全球範圍內嚴重的 COVID-19 病例的增加、各種有利的醫療保健報銷舉措以及開展的廣泛的研發 (R&D) 活動多個主要參與者在市場上引入先進的醫療設備。
The global oxygenators market size reached US$ 244.2 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 348.4 Million by 2028, exhibiting a growth rate (CAGR) of 5.9% during 2023-2028.
An oxygenator refers to a medical device that is routinely used in medical settings to help exchange oxygen and carbon dioxide from the patient's blood during surgical procedures. The device is used in conjunction with a heart-lung machine to facilitate gas exchange during procedures in which the blood flow is interrupted or stopped. These devices are widely used to manage heart-related disorders, such as cardiopulmonary, respiratory, and pulmonary disorders. As a result, these devices are commonly used in numerous critical surgical procedures, including cardiopulmonary bypass grafts (CABG) and coronary artery bypass grafts (CABG).
The global market is primarily driven by the growing number of hospital admissions due to the rising prevalence of numerous coronary, orthopedic and cardiovascular diseases among the masses. This can be attributed to the sedentary lifestyles led by individuals, resulting in various lifestyle-related ailments and a considerable rise in the requirement for surgical interventions. Additionally, the growing geriatric population that is susceptible to developing these diseases is also acting as a significant growth factor in the market. Additionally, the rising government investments in healthcare digitization, advanced infrastructure setup, and continual product innovations are fueling the market. As a result of improved healthcare settings, there has been a significant increase in the demand and sales for oxygenator devices across healthcare facilities on the global level. Some of the other factors contributing to the market include the increasing mergers and acquisitions (M&As) between key players, the augmenting cases of severe COVID-19 across the globe, various favorable healthcare reimbursement initiatives, and extensive research and development (R&D) activities conducted by multiple major players to introduce advanced medical devices in the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global oxygenators market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, age group and application.
Membrane Oxygenator
Bubble Oxygenator
Neonates
Pediatric
Adults
Respiratory
Cardiac
Extracorporeal Cardiopulmonary
Resuscitation (ECPR)
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Braile Biomedica, Chalice Medical Ltd, Eurosets S.r.l., Getinge AB, Livanova Plc, Medtronic plc, MicroPort, Nipro Corporation, Senko Medical Instrument Mfg. Co. Ltd., Terumo Medical Corporation (Terumo Corporation) and Xenios AG (Fresenius Medical Care AG & Co. KGaA).